These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851 [TBL] [Abstract][Full Text] [Related]
10. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons". Paraskevas KI J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983 [No Abstract] [Full Text] [Related]
11. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease. Hirsch AT; Treat-Jacobson D; Lando HA; Hatsukami DK Vasc Med; 1997; 2(3):243-51. PubMed ID: 9546975 [TBL] [Abstract][Full Text] [Related]
12. Medical and lifestyle management of peripheral arterial disease. Parvar SL; Fitridge R; Dawson J; Nicholls SJ J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849 [TBL] [Abstract][Full Text] [Related]
13. Peripheral arterial disease in the elderly: recognition and management. Aronow H Am J Cardiovasc Drugs; 2008; 8(6):353-64. PubMed ID: 19159122 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation. Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357 [TBL] [Abstract][Full Text] [Related]
15. Medical therapy for peripheral arterial disease. Simmons A; Steffen K; Sanders S Curr Opin Cardiol; 2012 Nov; 27(6):592-7. PubMed ID: 23032711 [TBL] [Abstract][Full Text] [Related]
16. Optimal medical management of peripheral arterial disease. Rice TW; Lumsden AB Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725 [TBL] [Abstract][Full Text] [Related]
17. Perceptions of Canadian Vascular Surgeons Toward Pharmacologic Risk Reduction in Patients with Peripheral Artery Disease: 2018 Update. Li B; Salata K; de Mestral C; Hussain MA; Aljabri BA; Lindsay TF; Verma S; Al-Omran M Ann Vasc Surg; 2019 Jul; 58():166-173.e4. PubMed ID: 30771465 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients. Hasimu B; Li J; Yu J; Ma Y; Zhao M; Nakayama T; Ma W; Yang J; Zheng L; Li X; Luo Y; Xu Y; Zhang L; Zou L; Xiao W; Han Y; Hu D Circ J; 2007 Jan; 71(1):95-9. PubMed ID: 17186985 [TBL] [Abstract][Full Text] [Related]
19. Peripheral arterial disease: a review of disease awareness and management. Watson K; Watson BD; Pater KS Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541 [TBL] [Abstract][Full Text] [Related]